118 related articles for article (PubMed ID: 31129907)
21. Impact of a dedicated cancer center surveillance program on guideline adherence for patients with stage II and III colorectal cancer.
Standeven L; Price Hiller J; Mulder K; Zhu G; Ghosh S; Spratlin JL
Clin Colorectal Cancer; 2013 Jun; 12(2):103-12. PubMed ID: 23153862
[TBL] [Abstract][Full Text] [Related]
22. Surveillance approaches among colorectal cancer survivors after curative-intent.
Haggstrom DA; Imperiale TF
Minerva Gastroenterol Dietol; 2009 Dec; 55(4):483-500. PubMed ID: 19942831
[TBL] [Abstract][Full Text] [Related]
23. Does serum CA19-9 play a practical role in the management of patients with colorectal cancer?
Morita S; Nomura T; Fukushima Y; Morimoto T; Hiraoka N; Shibata N
Dis Colon Rectum; 2004 Feb; 47(2):227-32. PubMed ID: 15043294
[TBL] [Abstract][Full Text] [Related]
24. Intensive surveillance following curative treatment of colorectal cancer allows effective treatment of recurrence even if limited to 4 years.
Adams K; Higgins L; Beazley S; Papagrigoriadis S
Int J Colorectal Dis; 2015 Dec; 30(12):1677-84. PubMed ID: 26320020
[TBL] [Abstract][Full Text] [Related]
25. Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified?
Yamamoto S; Akasu T; Fujita S; Moriya Y
Hepatogastroenterology; 2005; 52(62):444-9. PubMed ID: 15816454
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Impact of Preoperative Albumin-to-Globulin Ratio in Patients with Colon Cancer Undergoing Surgery with Curative Intent.
Fujikawa H; Toiyama Y; Inoue Y; Imaoka H; Shimura T; Okigami M; Yasuda H; Hiro J; Yoshiyama S; Saigusa S; Kobayashi M; Ohi M; Araki T; Mohri Y; Kusunoki M
Anticancer Res; 2017 Mar; 37(3):1335-1342. PubMed ID: 28314300
[TBL] [Abstract][Full Text] [Related]
27. The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer.
Moertel CG; O'Fallon JR; Go VL; O'Connell MJ; Thynne GS
Cancer; 1986 Aug; 58(3):603-10. PubMed ID: 3731019
[TBL] [Abstract][Full Text] [Related]
28. Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer.
Wanebo JH; Stearns M; Schwartz MK
Ann Surg; 1978 Oct; 188(4):481-93. PubMed ID: 697433
[TBL] [Abstract][Full Text] [Related]
29. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases.
Bowne WB; Lee B; Wong WD; Ben-Porat L; Shia J; Cohen AM; Enker WE; Guillem JG; Paty PB; Weiser MR
Dis Colon Rectum; 2005 May; 48(5):897-909. PubMed ID: 15785892
[TBL] [Abstract][Full Text] [Related]
30. Identification of patients with high-risk for pulmonary metastases after curative resection of colorectal cancer.
Anannamcharoen S; Boonya-Ussadol C
J Med Assoc Thai; 2012 May; 95 Suppl 5():S86-91. PubMed ID: 22934451
[TBL] [Abstract][Full Text] [Related]
31. Intensive Follow-Up After Curative Surgery for Colorectal Cancer.
Rodrigues RV; Pereira da Silva J; Rosa I; Santos I; Pereira N; Soares C; Pereira AD
Acta Med Port; 2017 Sep; 30(9):633-641. PubMed ID: 29025530
[TBL] [Abstract][Full Text] [Related]
32. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer.
McCall JL; Black RB; Rich CA; Harvey JR; Baker RA; Watts JM; Toouli J
Dis Colon Rectum; 1994 Sep; 37(9):875-81. PubMed ID: 8076486
[TBL] [Abstract][Full Text] [Related]
33. Value and cost of follow-up after adjuvant treatment of patients with Dukes' C colonic cancer.
Bleeker WA; Mulder NH; Hermans J; Otter R; Plukker JT
Br J Surg; 2001 Jan; 88(1):101-6. PubMed ID: 11136320
[TBL] [Abstract][Full Text] [Related]
34. Isolated paraaortic lymph-node recurrence after the curative resection of colorectal carcinoma.
Min BS; Kim NK; Sohn SK; Cho CH; Lee KY; Baik SH
J Surg Oncol; 2008 Feb; 97(2):136-40. PubMed ID: 17963247
[TBL] [Abstract][Full Text] [Related]
35. Perioperative cell-free DNA trends predict recurrence of non-metastatic colorectal cancer significantly earlier than CEA trends over the first 2 years post-operatively in stage II and stage III colon cancer.
Fleming CA; Jordan P; O'Leary DP; Corrigan MA; Wang JH; Redmond HP
Int J Colorectal Dis; 2022 May; 37(5):1119-1126. PubMed ID: 35441872
[TBL] [Abstract][Full Text] [Related]
36. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer.
Moertel CG; Fleming TR; Macdonald JS; Haller DG; Laurie JA; Tangen C
JAMA; 1993 Aug; 270(8):943-7. PubMed ID: 8141873
[TBL] [Abstract][Full Text] [Related]
37. An evaluation of postoperative follow-up tests in colon cancer patients treated for cure.
Peethambaram P; Weiss M; Loprinzi CL; Novotny P; O'Fallon JR; Erlichman C; O'Connell MJ; Laurie JA
Oncology; 1997; 54(4):287-92. PubMed ID: 9216852
[TBL] [Abstract][Full Text] [Related]
38. Strict follow-up programme including CT and ¹⁸F-FDG-PET after curative surgery for colorectal cancer.
Sørensen NF; Jensen AB; Wille-Jørgensen P; Friberg L; Rørdam L; Ingeman L; Hennild V
Colorectal Dis; 2010 Oct; 12(10 Online):e224-8. PubMed ID: 20002699
[TBL] [Abstract][Full Text] [Related]
39. [Anastomotic recurrence following colorectal cancer].
Lange V; Oevermann E; Schildberg FW
Zentralbl Chir; 1988; 113(22):1445-52. PubMed ID: 3063022
[TBL] [Abstract][Full Text] [Related]
40. Carcinoembryonic antigen (CEA) in diagnosis and prognosis of colorectal carcinoma.
Arnaud JP; Koehl C; Adloff M
Dis Colon Rectum; 1980 Apr; 23(3):141-4. PubMed ID: 7379666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
